1,4-Dimethoxybenzene

We are 1,4-Dimethoxybenzene CAS:150-78-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 150-78-7
Product Name: 1,4-Dimethoxybenzene
Other Name:
1,4-Dimethoxybenzene
4-Methoxyanisole
Hydroquinone Dimethyl Ether
Quinol dimethyl ether
Dimethylhydroquinone ether
2,5-dimethoxy-benzene
Dimethyl ether hydroquinone
p-Dimethoxybenzene
 
Density: 1.0±0.1 g/cm3
Boiling Point: 212.6±0.0 °C at 760 mmHg
Melting Point: 54-56 °C(lit.)
Molecular Formula: C8H10O2
Molecular Weight: 138.164
Flash Point: 73.5±19.4 °C
Exact Mass: 138.068085
PSA: 18.46000
LogP: 2.10
Vapour density: 4.8 (vs air)
Vapour Pressure: 0.3±0.4 mmHg at 25°C
Index of Refraction: 1.488
Stability: Stable. Combustible. Incompatible with strong oxidizing agents.
Water Solubility: 0.8 g/l (20 ºC)
 
Specification
Appearance: White or off-white crystalline powder
Assay: ≥99.0%
Water: ≤0.50%
 
Application
Be used as pharmaceutical intermediate.
Applicationd as an organic chemical intermediate, used in the production of drugs methoxyamine hydrochloride, dye black salt ANS, etc., also used as a fixing agent.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

1,4-Dimethoxybenzene


Related News: The on-body wear is similar to that of an insulin pump. Unlike insulin pump therapy, however, the investigational system is designed such that users enter only their body weight for the iLet to initialize therapy.212248-62-9 From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.4'-Aminobenzanilide Due to the time-consuming process of EIA approval and EIA acceptance for newly-built projects, and environmental protection supervision policies are becoming increasingly tight, the company strives to improve capacity utilization through reasonable equipment layout when designing and constructing capacity.757-86-8 In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of “predictable” clinical value for life-threatening diseases for which effective treatment is not immediately available.The primary endpoint of INSPIRE is overall survival. The trial continued beyond the pre-specified interim analysis and is nearing its conclusion.

Related Products
Product Name
2-甲基-3-甲硫基呋喃 View Details
2,3-Difluoro-5-methylbenzoic acid View Details
alanine View Details
2-Cyanobenzyl bromide manufacturer Bis(trimethoxysilylpropyl)amine manufacturer 3-Bromo-4-fluorotoluene manufacturer N,3-diphenylaniline manufacturer 3-Iodo-2-nitropyridine manufacturer